PDS Biotechnology (PDSB) Earnings Date, Estimates & Call Transcripts $1.09 +0.02 (+1.87%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.10 +0.01 (+0.92%) As of 08/1/2025 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDS Biotechnology Earnings Summary PDS Biotechnology released Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.21, which topped analysts' consensus estimates of -$0.25 by $0.04. With a trailing EPS of -$0.94, PDS Biotechnology's earnings are expected to decrease next year, from ($1.20) to ($1.35) per share. Upcoming Q2 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (May. 14) -$0.25 Actual EPS (May. 14) -$0.21 Beat By $0.04 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)PDSB Upcoming EarningsPDS Biotechnology's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get PDS Biotechnology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PDS Biotechnology and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPDSB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. PDS Biotechnology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.37-$0.31-$0.34Q2 20253-$0.37-$0.23-$0.28Q3 20253-$0.39-$0.21-$0.29Q4 20253-$0.41-$0.19-$0.30 PDS Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)-------5/14/2025Q1 2025-$0.25-$0.21+$0.04-$0.21--3/27/2025Q4 2024-$0.29-$0.21+$0.08-$0.21--8/13/2024Q2 2024-$0.31-$0.23+$0.08-$0.23--5/15/2024Q1 2024-$0.37-$0.30+$0.07-$0.30--3/27/2024Q4 2023-$0.39-$0.34+$0.05-$0.34--11/14/2023Q3 2023-$0.42-$0.35+$0.07-$0.35--8/14/2023Q2 2023-$0.37-$0.37--$0.37-- PDS Biotechnology Earnings - Frequently Asked Questions When is PDS Biotechnology's earnings date? PDS Biotechnology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on PDSB's earnings history. Did PDS Biotechnology beat their earnings estimates last quarter? In the previous quarter, PDS Biotechnology (NASDAQ:PDSB) reported ($0.21) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.04. Learn more on analysts' earnings estimate vs. PDSB's actual earnings. How can I listen to PDS Biotechnology's earnings conference call? The conference call for PDS Biotechnology's latest earnings report can be listened to online. Listen to Conference Call How can I read PDS Biotechnology's conference call transcript? The conference call transcript for PDS Biotechnology's latest earnings report can be read online. Read Transcript How much profit does PDS Biotechnology generate each year? PDS Biotechnology (NASDAQ:PDSB) has a recorded net income of -$37.61 million. PDSB has generated -$0.94 earnings per share over the last four quarters. What is PDS Biotechnology's EPS forecast for next year? PDS Biotechnology's earnings are expected to decrease from ($1.20) per share to ($1.35) per share in the next year. More Earnings Resources from MarketBeat Related Companies Caribou Biosciences Earnings Results 4D Molecular Therapeutics Earnings Results Alumis Earnings Results CARGO Therapeutics Earnings Results Instil Bio Earnings Results Organigram Global Earnings Results Eupraxia Pharmaceuticals Earnings Results CytomX Therapeutics Earnings Results enGene Earnings Results Kyverna Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Microsoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag? This page (NASDAQ:PDSB) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDS Biotechnology Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share PDS Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PDSB Stock Alerts